These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38334824)

  • 1. The effect of SP/NK1R on expression and activity of glutaredoxin and thioredoxin proteins in prostate cancer cells.
    Zarei Shandiz S; Assaran Darban R; Javid H; Ghahremanloo A; Hashemy SI
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Feb; ():. PubMed ID: 38334824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The SP/NK1R System-Mediated ROS Generation in GBM Cells through Inhibiting Glutaredoxin Protein.
    Mehrabani N; Vaezi Kakhki MR; Javid H; Ebrahimi S; Hashemy SI
    Neurol Res Int; 2021; 2021():9966000. PubMed ID: 34917417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The SP/NK1R system promotes the proliferation of breast cancer cells through NF-κB-mediated inflammatory responses.
    Jafarinezhad S; Assaran Darban R; Javid H; Hashemy SI
    Cell Biochem Biophys; 2023 Dec; 81(4):787-794. PubMed ID: 37740877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenic role of the SP/ NK1R system in GBM cells through inhibiting the thioredoxin system.
    Ghahremani F; Sabbaghzadeh R; Ebrahimi S; Javid H; Ghahremani J; Hashemy SI
    Iran J Basic Med Sci; 2021 Apr; 24(4):499-505. PubMed ID: 34094032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SP/NK1R system regulates carcinogenesis in prostate cancer: Shedding light on the antitumoral function of aprepitant.
    Ebrahimi S; Mirzavi F; Aghaee-Bakhtiari SH; Hashemy SI
    Biochim Biophys Acta Mol Cell Res; 2022 May; 1869(5):119221. PubMed ID: 35134443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Effect of Blocking Neurokinin-1 Receptor by Aprepitant on the Inflammatory and Apoptosis Pathways in Human Ovarian Cancer Cells.
    AlAlikhan A; Ghahremanloo A; Javid H; Ebrahimi S; Hashemy SI
    Cell Biochem Biophys; 2022 Dec; 80(4):819-827. PubMed ID: 36197642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effect of SP/NK1R on the Expression and Activity of Catalase and Superoxide Dismutase in Glioblastoma Cancer Cells.
    Korfi F; Javid H; Assaran Darban R; Hashemy SI
    Biochem Res Int; 2021; 2021():6620708. PubMed ID: 33976938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of substance P and its specific antagonist (aprepitant) on the expression of MMP-2, MMP-9, VEGF, and VEGFR in ovarian cancer cells.
    Momen Razmgah M; Ghahremanloo A; Javid H; AlAlikhan A; Afshari AR; Hashemy SI
    Mol Biol Rep; 2022 Oct; 49(10):9307-9314. PubMed ID: 35960409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential in vitro therapeutic effects of targeting SP/NK1R system in cervical cancer.
    Mozafari M; Ebrahimi S; Darban RA; Hashemy SI
    Mol Biol Rep; 2022 Feb; 49(2):1067-1076. PubMed ID: 34766230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The In Vitro Pro-inflammatory Functions of the SP/NK1R System in Prostate Cancer: a Focus on Nuclear Factor-Kappa B (NF-κB) and Its Pro-inflammatory Target Genes.
    Ebrahimi S; Erfani B; Alalikhan A; Ghorbani H; Farzadnia M; Afshari AR; Mashkani B; Hashemy SI
    Appl Biochem Biotechnol; 2023 Dec; 195(12):7796-7807. PubMed ID: 37093533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Therapeutic Potential of Aprepitant in Glioblastoma Cancer Cells through Redox Modification.
    Rezaei S; Assaran Darban R; Javid H; Hashemy SI
    Biomed Res Int; 2022; 2022():8540403. PubMed ID: 35281606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of the Role of Neurokinin-1 Receptor Inhibition Using Aprepitant in the Apoptotic Cell Death through PI3K/Akt/NF-
    Ghahremanloo A; Javid H; Afshari AR; Hashemy SI
    Biomed Res Int; 2021; 2021():1383878. PubMed ID: 34395609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatoblastoma cells express truncated neurokinin-1 receptor and can be growth inhibited by aprepitant in vitro and in vivo.
    Berger M; Neth O; Ilmer M; Garnier A; Salinas-Martín MV; de Agustín Asencio JC; von Schweinitz D; Kappler R; Muñoz M
    J Hepatol; 2014 May; 60(5):985-94. PubMed ID: 24412605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurokinin Receptor 1 (NK1R) Antagonist Aprepitant Enhances Hematoma Clearance by Regulating Microglial Polarization via PKC/p38MAPK/NFκB Pathway After Experimental Intracerebral Hemorrhage in Mice.
    Jin P; Deng S; Sherchan P; Cui Y; Huang L; Li G; Lian L; Xie S; Lenahan C; Travis ZD; Zhang JH; Gong Y; Tang J
    Neurotherapeutics; 2021 Jul; 18(3):1922-1938. PubMed ID: 34244927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-34b/c-5p and the neurokinin-1 receptor regulate breast cancer cell proliferation and apoptosis.
    Zhang L; Wang L; Dong D; Wang Z; Ji W; Yu M; Zhang F; Niu R; Zhou Y
    Cell Prolif; 2019 Jan; 52(1):e12527. PubMed ID: 30334298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-HIV-1 activity of the neurokinin-1 receptor antagonist aprepitant and synergistic interactions with other antiretrovirals.
    Manak MM; Moshkoff DA; Nguyen LT; Meshki J; Tebas P; Tuluc F; Douglas SD
    AIDS; 2010 Nov; 24(18):2789-96. PubMed ID: 20975512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aprepitant inhibits the progression of esophageal squamous cancer by blocking the truncated neurokinin‑1 receptor.
    Zheng Y; Sang M; Liu F; Gu L; Li J; Wu Y; Shan B
    Oncol Rep; 2023 Jul; 50(1):. PubMed ID: 37203393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the Neurokinin-1 Receptor Compromises Canonical Wnt Signaling in Hepatoblastoma.
    Ilmer M; Garnier A; Vykoukal J; Alt E; von Schweinitz D; Kappler R; Berger M
    Mol Cancer Ther; 2015 Dec; 14(12):2712-21. PubMed ID: 26516161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the neurokinin-1 receptor inhibits growth of human colon cancer cells.
    Garnier A; Vykoukal J; Hubertus J; Alt E; von Schweinitz D; Kappler R; Berger M; Ilmer M
    Int J Oncol; 2015 Jul; 47(1):151-60. PubMed ID: 25998227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aprepitant Promotes Caspase-Dependent Apoptotic Cell Death and G2/M Arrest through PI3K/Akt/NF-
    Javid H; Afshari AR; Zahedi Avval F; Asadi J; Hashemy SI
    Biomed Res Int; 2021; 2021():8808214. PubMed ID: 34926694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.